181 related articles for article (PubMed ID: 35397094)
1. Evolution of acute "black hole" lesions in patients with relapsing-remitting multiple sclerosis.
Kostic D; Dincic E; Jovanovski A; Kostic S; Rancic N; Georgievski-Brkic B; Misovic M; Koprivsek K
Acta Neurol Belg; 2023 Jun; 123(3):831-838. PubMed ID: 35397094
[TBL] [Abstract][Full Text] [Related]
2. Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
Dadar M; Mahmoud S; Narayanan S; Collins DL; Arnold DL; Maranzano J
Brain; 2022 Jun; 145(6):2008-2017. PubMed ID: 34927199
[TBL] [Abstract][Full Text] [Related]
3. CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.
Khormi I; Al-Iedani O; Casagranda S; Papageorgakis C; Alshehri A; Lea R; Liebig P; Ramadan S; Lechner-Scott J
Magn Reson Imaging; 2023 Oct; 102():212-221. PubMed ID: 37321380
[TBL] [Abstract][Full Text] [Related]
4. T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple Sclerosis.
Thaler C; Faizy TD; Sedlacik J; Holst B; Stürner K; Heesen C; Stellmann JP; Fiehler J; Siemonsen S
AJNR Am J Neuroradiol; 2017 Feb; 38(2):264-269. PubMed ID: 28059711
[TBL] [Abstract][Full Text] [Related]
5. Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.
Radue EW; Sprenger T; Vollmer T; Giovannoni G; Gold R; Havrdova E; Selmaj K; Stefoski D; You X; Elkins J
Eur J Neurol; 2016 Feb; 23(2):412-5. PubMed ID: 26806217
[TBL] [Abstract][Full Text] [Related]
6. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.
Elliott C; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Wei W; Belachew S; Arnold DL
Mult Scler; 2019 Dec; 25(14):1915-1925. PubMed ID: 30566027
[TBL] [Abstract][Full Text] [Related]
7. Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis.
Calvi A; Tur C; Chard D; Stutters J; Ciccarelli O; Cortese R; Battaglini M; Pietroboni A; De Riz M; Galimberti D; Scarpini E; De Stefano N; Prados F; Barkhof F
Neuroimage Clin; 2022; 35():103048. PubMed ID: 35598462
[TBL] [Abstract][Full Text] [Related]
8. Characterization of white matter lesions in multiple sclerosis using proton density and T1-relaxation measures.
Buch S; Subramanian K; Chen T; Chen Y; Larvie M; Bernitsas E; Haacke EM
Magn Reson Imaging; 2024 Feb; 106():110-118. PubMed ID: 38145698
[TBL] [Abstract][Full Text] [Related]
9. Quantitative susceptibility mapping of both ring and non-ring white matter lesions in relapsing remitting multiple sclerosis.
Coffman CH; White R; Subramanian K; Buch S; Bernitsas E; Haacke EM
Magn Reson Imaging; 2022 Sep; 91():45-51. PubMed ID: 35605736
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
[TBL] [Abstract][Full Text] [Related]
11. Peginterferon beta-1a reduces the evolution of MRI lesions to black holes in patients with RRMS: a post hoc analysis from the ADVANCE study.
Arnold DL; You X; Castrillo-Viguera C
J Neurol; 2017 Aug; 264(8):1728-1734. PubMed ID: 28685353
[TBL] [Abstract][Full Text] [Related]
12. Improving acute demyelinating lesion detection: which T1-weighted magnetic resonance acquisition is more sensitive to gadolinium enhancement?
Amaral LLFD; Fragoso DC; Rocha AJD
Arq Neuropsiquiatr; 2019 Jul; 77(7):485-492. PubMed ID: 31365640
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different MR Imaging Sequences.
do Amaral LLF; Fragoso DC; Nunes RH; Littig IA; da Rocha AJ
AJNR Am J Neuroradiol; 2019 Apr; 40(4):614-619. PubMed ID: 30846435
[TBL] [Abstract][Full Text] [Related]
14. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
[TBL] [Abstract][Full Text] [Related]
15. MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.
Maranzano J; Rudko DA; Nakamura K; Cook S; Cadavid D; Wolansky L; Arnold DL; Narayanan S
Neurology; 2017 Aug; 89(7):714-721. PubMed ID: 28724581
[TBL] [Abstract][Full Text] [Related]
16. Spatial distribution of white matter degenerative lesions and cognitive dysfunction in relapsing-remitting multiple sclerosis patients.
Nowaczyk N; Kalinowska-Łyszczarz A; Paprzycki W; Michalak S; Kaźmierski R; Pawlak MA
Neurol Neurochir Pol; 2019; 53(1):18-25. PubMed ID: 30742302
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis.
Ciccarelli O; Giugni E; Paolillo A; Mainero C; Gasperini C; Bastianello S; Pozzilli C
Eur J Neurol; 1999 Jul; 6(4):455-9. PubMed ID: 10362899
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.
Chiang GC; Pinto S; Comunale JP; Gauthier SA
J Neuroimaging; 2016 May; 26(3):289-95. PubMed ID: 26458494
[TBL] [Abstract][Full Text] [Related]
19. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
Vellinga MM; Oude Engberink RD; Seewann A; Pouwels PJ; Wattjes MP; van der Pol SM; Pering C; Polman CH; de Vries HE; Geurts JJ; Barkhof F
Brain; 2008 Mar; 131(Pt 3):800-7. PubMed ID: 18245785
[TBL] [Abstract][Full Text] [Related]
20. T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
Thaler C; Faizy T; Sedlacik J; Holst B; Stellmann JP; Young KL; Heesen C; Fiehler J; Siemonsen S
PLoS One; 2015; 10(12):e0144693. PubMed ID: 26659852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
